Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation. [electronic resource]
Producer: 20041101Description: 1121-31 p. digitalISSN:- 1019-6439
- Adenocarcinoma -- blood supply
- Angiogenesis Inhibitors -- therapeutic use
- Animals
- Blotting, Western
- Carcinoma, Lewis Lung -- blood supply
- Cell Hypoxia -- drug effects
- Cell Survival -- drug effects
- Collagen -- chemistry
- Combined Modality Therapy
- Drug Combinations
- Female
- Hypoxia-Inducible Factor 1, alpha Subunit
- Laminin -- chemistry
- Mammary Neoplasms, Experimental -- blood supply
- Mice
- Mice, Inbred C57BL
- Necrosis
- Neovascularization, Pathologic -- prevention & control
- Proteoglycans -- chemistry
- Quinoxalines -- therapeutic use
- Radiation Tolerance
- Radiation, Ionizing
- Radiation-Sensitizing Agents
- Reverse Transcriptase Polymerase Chain Reaction
- Transcription Factors -- genetics
- Tumor Cells, Cultured
- Tumor Stem Cell Assay
- Vascular Endothelial Growth Factor A -- genetics
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.